106 related articles for article (PubMed ID: 9437494)
1. Sirolimus in transplantation.
Stepkowski SM; Tian L; Wang ME; Qu X; Napoli K; Kahan BD
Arch Immunol Ther Exp (Warsz); 1997; 45(5-6):383-90. PubMed ID: 9437494
[TBL] [Abstract][Full Text] [Related]
2. Addition of sirolimus to cyclosporine in long-term kidney transplant recipients to withdraw steroid.
Citterio F; Sparacino V; Altieri P; Rigotti P; Calabrese S; Poli M; Vinti V; Segoloni GP
Transplant Proc; 2005 Mar; 37(2):827-9. PubMed ID: 15848545
[TBL] [Abstract][Full Text] [Related]
3. Sirolimus, a new, potent immunosuppressive agent.
Kelly PA; Gruber SA; Behbod F; Kahan BD
Pharmacotherapy; 1997; 17(6):1148-56. PubMed ID: 9399599
[TBL] [Abstract][Full Text] [Related]
4. Conversion to sirolimus-based maintenance immunosuppression using daclizumab bridge therapy in renal transplant recipients.
Sundberg AK; Rohr MS; Hartmann EL; Adams PL; Stratta RJ
Clin Transplant; 2004; 18 Suppl 12():61-6. PubMed ID: 15217410
[TBL] [Abstract][Full Text] [Related]
5. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
Gaber AO; Kahan BD; Van Buren C; Schulman SL; Scarola J; Neylan JF;
Transplantation; 2008 Nov; 86(9):1187-95. PubMed ID: 19005398
[TBL] [Abstract][Full Text] [Related]
6. Incidence of posttransplant diabetes mellitus in kidney transplant recipients immunosuppressed with sirolimus in combination with cyclosporine.
Romagnoli J; Citterio F; Nanni G; Favi E; Tondolo V; Spagnoletti G; Salerno MP; Castagneto M
Transplant Proc; 2006 May; 38(4):1034-6. PubMed ID: 16757255
[TBL] [Abstract][Full Text] [Related]
7. Two-year incidence of malignancy in sirolimus-treated renal transplant recipients: results from five multicenter studies.
Mathew T; Kreis H; Friend P
Clin Transplant; 2004 Aug; 18(4):446-9. PubMed ID: 15233824
[TBL] [Abstract][Full Text] [Related]
8. Long-term improvement in renal function with sirolimus after early cyclosporine withdrawal in renal transplant recipients: 2-year results of the Rapamune Maintenance Regimen Study.
Oberbauer R; Kreis H; Johnson RW; Mota A; Claesson K; Ruiz JC; Wilczek H; Jamieson N; Henriques AC; Paczek L; Chapman J; Burke JT;
Transplantation; 2003 Jul; 76(2):364-70. PubMed ID: 12883194
[TBL] [Abstract][Full Text] [Related]
9. Sirolimus-based therapy with or without cyclosporine: long-term follow-up in renal transplant patients.
Morales JM; Campistol JM; Kreis H; Mourad G; Eris J; Schena FP; Grinyo JM; Nanni G; Andres A; Castaing N; Brault Y; Burke JT
Transplant Proc; 2005 Mar; 37(2):693-6. PubMed ID: 15848504
[TBL] [Abstract][Full Text] [Related]
10. Human allograft arterial injury is ameliorated by sirolimus and cyclosporine and correlates with suppression of interferon-gamma.
Yi T; Cuchara L; Wang Y; Koh KP; Ranjbaran H; Tellides G; Pober JS; Lorber MI
Transplantation; 2006 Feb; 81(4):559-66. PubMed ID: 16495804
[TBL] [Abstract][Full Text] [Related]
11. Immunosuppressant use without bone loss--implications for bone loss after transplantation.
Goodman GR; Dissanayake IR; Sodam BR; Gorodetsky E; Lu J; Ma YF; Jee WS; Epstein S
J Bone Miner Res; 2001 Jan; 16(1):72-8. PubMed ID: 11149492
[TBL] [Abstract][Full Text] [Related]
12. The role and value of sirolimus administration in kidney and liver transplantation.
Mehrabi A; Fonouni H; Kashfi A; Schmied BM; Morath Ch; Sadeghi M; Schemmer P; Encke J; Sauer P; Zeier M; Weitz J; Büchler MW; Schmidt J
Clin Transplant; 2006; 20 Suppl 17():30-43. PubMed ID: 17100699
[TBL] [Abstract][Full Text] [Related]
13. Three-year health-related quality-of-life outcomes for sirolimus-treated kidney transplant patients after elimination of cyclosporine.
Russ G; Jamieson N; Oberbauer R; Arias M; Murgia MG; Blancho G; Sato R; Stoeckl M; Revicki DA
Transpl Int; 2007 Oct; 20(10):875-83. PubMed ID: 17854445
[TBL] [Abstract][Full Text] [Related]
14. Synergistic mechanisms by which sirolimus and cyclosporin inhibit rat heart and kidney allograft rejection.
Stepkowski SM; Tian L; Napoli KL; Ghobrial R; Wang ME; Chou TC; Kahan BD
Clin Exp Immunol; 1997 Apr; 108(1):63-8. PubMed ID: 9097913
[TBL] [Abstract][Full Text] [Related]
15. Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation.
Campistol JM; Eris J; Oberbauer R; Friend P; Hutchison B; Morales JM; Claesson K; Stallone G; Russ G; Rostaing L; Kreis H; Burke JT; Brault Y; Scarola JA; Neylan JF
J Am Soc Nephrol; 2006 Feb; 17(2):581-9. PubMed ID: 16434506
[TBL] [Abstract][Full Text] [Related]
16. Preclinical results of sirolimus treatment in transplant models.
Stepkowski SM
Transplant Proc; 2003 May; 35(3 Suppl):219S-226S. PubMed ID: 12742499
[TBL] [Abstract][Full Text] [Related]
17. Health-related quality-of-life outcomes of sirolimus-treated kidney transplant patients after elimination of cyclosporine A: results of a 2-year randomized clinical trial.
Oberbauer R; Hutchison B; Eris J; Arias M; Claesson K; Mota A; Kreis H; Kleinman L; Wang F; Chen J; Revicki DA;
Transplantation; 2003 Apr; 75(8):1277-85. PubMed ID: 12717216
[TBL] [Abstract][Full Text] [Related]
18. Different renal toxicity profiles in the association of cyclosporine and tacrolimus with sirolimus in rats.
Lloberas N; Torras J; Alperovich G; Cruzado JM; Giménez-Bonafé P; Herrero-Fresneda I; Franquesa Ml; Rama I; Grinyó JM
Nephrol Dial Transplant; 2008 Oct; 23(10):3111-9. PubMed ID: 18469305
[TBL] [Abstract][Full Text] [Related]
19. Orthotopic liver transplantation using low-dose tacrolimus and sirolimus.
McAlister VC; Peltekian KM; Malatjalian DA; Colohan S; MacDonald S; Bitter-Suermann H; MacDonald AS
Liver Transpl; 2001 Aug; 7(8):701-8. PubMed ID: 11510015
[TBL] [Abstract][Full Text] [Related]
20. Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantation.
Oberbauer R; Segoloni G; Campistol JM; Kreis H; Mota A; Lawen J; Russ G; Grinyó JM; Stallone G; Hartmann A; Pinto JR; Chapman J; Burke JT; Brault Y; Neylan JF;
Transpl Int; 2005 Jan; 18(1):22-8. PubMed ID: 15612979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
